After split from Actelion, Idorsia CEO plans to raise more cash in 2019

* Idorsia spun off from Swiss biotech firm Actelion in 2017

* J&J invested $1 bln as part of deal

* Late-stage trials on four drugs getting under way - CEO Clozel

* Clozel pledges no 'crazy price' for key insomnia drug